Food, drugs, devices › Heritage Pharmaceuticals Inc
Drug recall: Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 0881
FDA enforcement event 87762 is a drug recall by Heritage Pharmaceuticals Inc of East Brunswick, NJ, initiated 21 Apr 2021 and classified Class III, with 1 product record.
FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 21% of the 299 drug enforcement events initiated in 2021 carry the same class.
Status: Terminated, terminated 9 Jun 2022. Initiation: voluntary: firm initiated. Heritage Pharmaceuticals Inc has 12 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Heritage Pharmaceuticals Inc, East Brunswick, NJ.
Reason for recall
"Labeling: Incorrect or Missing Lot and/or Exp Date"
Distribution
"OH"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-0367-2021 | Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle | 408 bottles | Class III | Terminated | 12 May 2021 |
Context
Other enforcement events for Heritage Pharmaceuticals Inc
All 12 events for Heritage Pharmaceuticals Inc
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Labeling: Incorrect or Missing Lot and/or Exp Date"
What does Class III mean?
FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
Where was the product distributed?
FDA's distribution pattern field reads: "OH"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 9 Jun 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.